Decoy Therapeutics Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $8.3M | $7.8M | $10.7M | $4.8M | $794.9K | $1.8M | $2.4M | $3.3M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $8.6M | $8.4M | $11.0M | $6.1M | $1.4M | $2.3M | $3.0M | $3.8M |
| Property, Plant & Equipment | $399.1K | $35.7K | $40.6K | — | — | — | $0 | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $9.0M | $8.4M | $11.1M | $6.1M | $1.4M | $2.3M | $3.0M | $3.9M |
| Liabilities | ||||||||
| Accounts Payable | $1.3M | $936.0K | $940.6K | $1.1M | $1.5M | $1.5M | $937.0K | $165.8K |
| Total Current Liabilities | $4.7M | $4.5M | $5.2M | — | — | — | $1.5M | — |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $4.7M | $4.5M | $5.2M | $1.8M | $2.2M | $2.3M | $1.5M | $934.6K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-99.0M | $-96.7M | $-94.4M | $-85.5M | $-84.6M | $-83.6M | $-81.9M | $-80.5M |
| Total Stockholders' Equity | $4.3M | $3.9M | $5.9M | $4.2M | $-829.7K | $61.9K | $1.5M | $2.9M |